IBC Pharmaceuticals, Inc.

2 articles with IBC Pharmaceuticals, Inc.

• Immunomedics, Inc. Constructs New Bispecific Antibodies Using The Dock And Lock (DNL) Technology

  6/5/2006

• Immunomedics, Inc. And IBC Pharmaceuticals, Inc. Report On A Novel Protein Engineering Platform Technology

  4/25/2006